This bill requires New Jersey health insurance companies to cover mental health treatment and therapy for victims of domestic violence as "medically necessary," eliminating insurance denials for these services. It directly affects insurance carriers (who must provide full coverage) and domestic violence victims (who gain guaranteed access to mental health care). The key provision mandates that such treatment be covered "to the same extent as any other medically necessary treatment" under a policy, removing barriers insurers previously used to limit coverage. The bill amends multiple insurance law sections to enforce this requirement, applying to all health insurance contracts.
This bill requires all health insurance plans in New Jersey that cover prostheses to include coverage for hair headpieces (human or artificial) worn to conceal scalp hair loss caused by chemotherapy for cancer patients. It applies to hospital service corporations, medical service corporations, health service corporations, individual policies, group policies, and health benefits plans. Coverage is mandatory only when a treating physician provides a written recommendation that the headpiece is medically necessary, and it must follow the same limitations as other prostheses under the plan. The law affects cancer patients undergoing chemotherapy who rely on insurance for these headpieces, ensuring they are covered under existing prosthetic coverage rules.
This New Jersey bill (A2483) requires health insurance plans to cover scalp cooling systems used during cancer chemotherapy to prevent hair loss. It applies to all major insurance types in the state - hospital service contracts, medical service contracts, individual policies, group plans, and health benefits plans - that already cover chemotherapy. Insurers must provide this coverage "to the same extent as for any other condition" under the policy, without additional patient cost. The bill directly affects cancer patients receiving chemotherapy who may use scalp cooling devices, ensuring these treatments are covered as part of standard medical benefits.
This New Jersey bill (A 1509) creates a binding arbitration process for disputes between health insurance companies (carriers) and healthcare providers (like doctors' offices or clinics) over payment rates. If negotiations fail, either party can trigger arbitration by submitting their final payment offer to the state Department of Banking and Insurance, with the arbitrator selecting one of the two offers. The bill requires carriers to notify patients 30 days before open enrollment if a provider will be out-of-network starting the next plan year, while ensuring continued in-network coverage and reimbursement until the new plan year begins. It directly affects health insurers, healthcare providers, and patients who rely on these networks for coverage.
This bill requires New Jersey health insurance carriers to offer "clear cost share plans" for individual health insurance plans. These standardized plans would feature transparent, consistent copayments, coinsurance, and deductibles for covered services across bronze, silver, and gold metal tiers (as defined by federal law). The commissioner of Banking and Insurance must develop these plans, focusing on reducing out-of-pocket barriers and making plan comparisons clearer for consumers. It applies to individual health plans issued on or after January 1, 2023, and allows carriers to offer up to three modified plans with commissioner approval.
This New Jersey bill (A 2452) establishes a constitutional right to access abortion care, including termination of pregnancy, and requires health insurance plans to cover abortion services without cost-sharing (like deductibles or copays). It repeals conflicting state regulations that previously restricted abortion coverage in health plans and state-funded programs. The bill appropriates $20 million to support reproductive health services and defines key terms like "medical abortion" and "practical support" (e.g., transportation, lodging for care access). It directly affects residents seeking abortion care, health insurers, and state agencies administering health programs.
This bill (A 2308) requires New Jersey health insurance carriers to cover enrollment in recovery high school alternative education programs for students with substance use disorders. It directly affects students in these programs and health insurers, mandating coverage when a certified professional (like a counselor or physician) determines it is clinically appropriate based on DSM criteria. The law specifies that this coverage must be provided under the same terms as other medical benefits, without extra copays, deductibles, or limits. It amends existing insurance laws to include this specific benefit for recovery high schools established under P.L.2015, c.254. The bill is currently pending before the Assembly Financial Institutions and Insurance Committee.
This bill (A2236) requires New Jersey health insurance carriers to automatically approve physician credentialing applications if the physician holds a valid New Jersey medical license in good standing. It mandates the use of a standardized universal application form, eliminating redundant approval steps for physicians seeking to join or renew network participation. The law applies immediately to all applications received after enactment, streamlining the process for physicians licensed in New Jersey. This directly affects physicians and healthcare providers seeking to participate in insurance carrier networks.
This New Jersey bill (A 2537) prohibits health insurance carriers from requiring prior authorization when a doctor prescribes an interchangeable drug if the brand-name drug or its generic version is unavailable. It directly affects patients, doctors, and insurers by removing a common administrative barrier that delays access to certain medications. The law defines "carriers" as insurance companies, health plans, or entities managing state health programs, and mandates they cannot block prescriptions for interchangeable drugs under the specified availability conditions. The bill takes effect immediately upon enactment.
This New Jersey bill (S 3262) requires all health insurance plans sold in the state to cover medically necessary Lyme disease treatment recommended by a doctor. It applies to every type of health insurance policy - individual, group, HMOs, and state health plans - mandating coverage for treatment deemed necessary by a physician. The bill specifically prohibits insurers from denying coverage solely because a treatment is labeled "experimental" or "investigational." This directly affects New Jersey residents with health insurance and their providers, ensuring access to Lyme disease care without insurer loopholes.
